JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 1994, p. 903-905
0095-1 137/94/$04.00+0
Copyright ©) 1994, American Society for Microbiology
Vol. 32, No. 4
Diagnostic Utility -of PCR-Enzyme Immunoassay, Culture, and
Serology for Detection of Chlamydia pneumoniae in
Symptomatic and Asymptomatic Patients
CHARLOYTE A. GAYDOS,' PATRICIA M. ROBLIN,2 MARGARET R. HAMMERSCHLAG,2
CHARLES L. HYMAN,2 JOSEPH J. EIDEN,' JULIUS SCHACHTER,3 AND THOMAS C. QUINN14*
Departments of Medicine and Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, 1 and
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda,4 Maryland;
Departments of Medicine and Pediatrics, SUNY Health Science Center at Brooklyn, New York, New York,2 and
Department of Laboratory Medicine, University of California, San Francisco, California3
To assess the utility of PCR-enzyme immunoassay (EIA) for diagnosis of acute infection with Chlamydia
pneumoniae, we compared tissue culture, PCR-EIA, direct fluorescent-antibody (DFA) stain, and serology in
studies with 56 patients with respiratory symptoms and 80 asymptomatic persons. Thirty-five patients were
positive by either culture or PCR-EIA, and 101 were negative by both assays. Thirty specimens from
symptomatic patients and one from an asymptomatic patient were culture positive; 23 of these were also
PCR-EIA positive. Of the eight culture-positive, PCR-EIA-negative specimens, five were DFA negative and three
were DFA positive. Four additional specimens were culture negative and PCR-EIA positive; of these, three were
DFA positive and one was DFA negative. When we used culture- and/or DFA-positive results as a reference or
"gold standard," the sensitivity and specificity of PCR were 76.5 and 99.0%, respectively. When we used PCRand/or DFA-positive results as the reference, the sensitivity of culture was 87.5%. On the basis of single acute
serum specimens, only 8 of these 35 patients had diagnostic antibody titers. Of the asymptomatic patients, 75%
had immunoglobulin G or immunoglobulin M antibody to C. pneumoniae; 15 (18.8%) of these had antibody levels
considered to be diagnostic of acute infection. This multicenter study indicates that culture and/or PCR-EIA is
more reliable for prompt diagnosis of C. pneumoniae infection than single-point serology alone.
Chlamydia pneumoniae is an important respiratory pathogen
and has been implicated as a cause of up to 10% of cases of
community-acquired pneumonia (5, 7). It has also been associated with asthma, bronchitis, pharyngitis, acute chest syndrome, and coronary heart disease (6, 8, 10). Serology for C.
pneumoniae antibodies has been used for diagnosis in most of
these studies (2, 7). Since serology based on paired sera is
useful only retrospectively and culture may take 3 to 7 days for
a result to be obtained, a rapid method such as PCR may be
advantageous because it offers more timely treatment options.
Previous studies have demonstrated that PCR can be used to
detect C. pneumoniae (4). However, those initial studies did
not determine the sensitivity or specificity of PCR by testing a
large number of clinical specimens in parallel with cultures
from symptomatic and asymptomatic individuals. We therefore
initiated a study to determine the usefulness of PCR compared
with culture for the rapid diagnosis of acute C. pneumoniae
infections (4). In addition, this PCR has been adapted for
detection of amplified DNA products by enzyme immunoassay
(EIA), thereby offering a diagnostic tool for screening large
numbers of clinical specimens (3).
asymptomatic adult persons (n = 80) were cultured for C.
pneumoniae. The symptomatic patients were randomly selected patients who were being evaluated for C. pneumoniae
infection or were part of ongoing studies from 1989 to 1993 of
the association of C. pneumoniae and asthma, pneumonia, or
cystic fibrosis in children and adults from New York, N.Y. The
asymptomatic persons were healthy adult health-care workers
in Brooklyn without respiratory symptoms during the prior 3
months and without a known history of C. pneumoniae infection. Serological studies were performed at a different institution (the University of California), without knowledge of the
culture results. Culture transport media (1.5 ml of 2-sucrose
phosphate media) were stored at - 70°C and were retrospectively analyzed by PCR-EIA at a third institution (The Johns
Hopkins University), without culture or serology results being
known.
Cultures were performed by inoculating 200 [l of the
specimen in chlamydia transport media into HEp-2 cells in
96-well microtiter plates, and negative cultures were passed
once to fresh cells (9). Isolates were identified as chlamydiae
with genus-specific fluorescein-conjugated monoclonal antisera (culture confirmation reagent; Sanofi Diagnostics Pasteur,
Chaska, Minn.), and their identities were confirmed by using
C. pneumoniae-specific monoclonal antibody (Washington Research Foundation, Seattle, Wash.). Isolates were also stained
by anti-major outer membrane protein, Chlamydia trachomatis-specific monoclonal antisera (Syva, Palo Alto, Calif.) to
identify C. trachomatis. Aliquots of the original culture transport medium were shipped on dry ice for analysis by PCR-EIA
and direct fluorescent-antibody (DFA) staining. Two hundred
microliters of the specimen was lysed by proteinase K-detergent treatment and dialyzed. Fifty microliters was then ampli-
MATERIALS AND METHODS
Nasopharyngeal specimens, collected with dacron-tipped
wire shaft swabs, from a group of 42 pediatric and 14 adult
patients with respiratory symptoms (n = 56) and a group of
*
Corresponding author. Mailing address: Division of Infectious
Diseases, The Johns Hopkins University School of Medicine, Ross
Research Building 1159, 720 Rutland Ave., Baltimore, MD 212052196.
903
Downloaded from http://jcm.asm.org/ on July 24, 2020 by guest
Received 8 September 1993/Returned for modification 30 November 1993/Accepted 27 December 1993
J. CLIN. MICROBIOL.
GAYDOS ET AL.
904
TABLE 1. IgG and IgM titers for specimens positive for C.
pneumoniae by culture and PCR-EIA
Titer" of:
Specimen
b
IgGb
086 (asymptomatic)
T 2244
A 155
A 147
1:16
-
No. of samples with result by:
IgmC
-
1:64
1:128
1:32
1:128
1:128
1:256
1:16
1:1024
1:1024
>1:256
-
-
1:16
1:32
1:32
-
-
1:64
-
1:32
1:32
1:64
-
Positive
Negative
Positive
23
8
4
101
26
8
Negative Positive
Negative
1
101
Culture
Positive
Negative
28
4
3
101
-
-
Noned
-
-
1:32
-
-
-
1:256
1:8
1:16
PCR-EIA
Positive
Negative
PCR-EIA and/or
DFA
Culture and/or
DFA
Culture
Test and result
-
1:16
Negative (-) result indicates a titer of < 1:16.
Single IgG titers of .1:512 are considered to be diagnostic of acute infection.
IgM antibody levels of .1:16 are considered to be diagnostic of acute
infection with C. pneumoniae.
d No serum sample available.
a
b
fied in a microtiter format in a 9600 thermocycler (PerkinElmer Cetus) (3). The C. pneumoniae-specific PCR was based
on primers from the 16S rRNA gene (4). PCR products were
detected by an EIA following hybridization with a 270-bp
biotinylated RNA probe to nested sequences within the amplicon (1, 3). The biotin-labeled DNA-RNA hybrid was captured in antibiotin-coated 96-well microtiter plates. Discrepant
results of culture and PCR-EIA were analyzed by spinning the
culture transport media and performing a DFA stain of the
sediment for elementary bodies with Sanofi Diagnostics culture confirmation reagent. Sera were assayed by microimmunofluorescence for immunoglobulin G (IgG) and IgM antibodies (11).
then tissue culture would have a sensitivity of 88.6% and a
specificity of 100%. PCR-EIA would be 77.1% sensitive and
100% specific. One specimen was positive for C. trachomatis by
culture and negative by the C. pneumoniae-specific PCR-EIA.
On the basis of a single serum specimen from each of these
35 patients, 8 (22.9%) had titers considered to be diagnostic of
acute infection (Tables 1 and 3). For one patient no serum
sample was available. Of the 23 individuals who were both
culture and PCR-EIA positive, 12 (52.2%) demonstrated levels
of IgG antibody to C. pneumoniae of -1:32, but only 6 of these
patients also had IgM antibody levels of .1:16 and one
additional patient had only a high IgG antibody level (Table 1).
Therefore, only 7 (30.4%) of these 23 patients met diagnostic
criteria for a serological diagnosis of active infection based on
a single serum sample. However, since paired specimens are
usually used to determine acute infection by serodiagnosis,
more of these individuals might have had diagnostic titers if
convalescent sera had been available.
Only one of the asymptomatic patients was both culture and
PCR-EIA positive. However, 60 (75%) of 80 were antibody
positive (IgG level of .1:32) by microimmunofluorescence.
Fifteen (18.8%) of these asymptomatic patients met diagnostic
criteria for acute infection, as indicated by Grayston et al. (5),
by demonstrating IgM antibody levels of .1:16 (n = 10) or
IgG levels of -1:512 (n = 5) in serology.
TABLE 3. Discrepant results of culture, PCR-EIA, and DFA
RESULTS
Of 136 patients (56 symptomatic and 80 asymptomatic)
tested, 35 were positive by either culture or PCR-EIA and 101
were negative. Thirty-one were tissue culture positive and 27
were PCR-EIA positive. Only one specimen positive by both
assays was from an asymptomatic patient. There were 23
specimens positive by both tests (Table 1). There were 12
specimens with discrepant culture and PCR-EIA results; 3
were culture positive, PCR-EIA negative, and DFA positive.
Five were culture positive, PCR-EIA negative, and DFA
negative. Four specimens were culture negative and PCR-EIA
positive, of which three were DFA positive (Table 2). Before
discrepant results were resolved, the sensitivity and specificity
of PCR-EIA were 74.2 and 96.2%, respectively. When we used
DFA to resolve discrepant results, the revised sensitivity and
specificity of culture were 87.5 and 97.1%, respectively, and
those of PCR-EIA were 76.5 and 99.0%, respectively. If either
culture or PCR-EIA positivity were accepted as true positivity,
Test result by:
PCR-EIA
Culture (no. of
inclusions/well)
Specimen
ASK 20
ASK 29
T2224
T2229
ASK 18
T2382
T2444
CF3
087
A192
T2259
+
+
+
+
+
+
-
(2, second passage)
(10, second passage)
(1, second passage)
(>100)
(35)
(14)
Titer" of:
IgGb IgMc
1:8
-
+
+
-
-
-
-
-
-
1:16
-
-
+
+
+
+
1:128
1:32
1:32
+
+
+ (10)
+ (5)
-
DFA
-
-
+
+
-
-
1:32
1:256
1:256
-
_
-
+
(-)
result indicates a titer of <1:16.
a Negative
b
are considered to be diagnostic of acute infection.
Single IgG titers of
'
IgM antibody levels of .1:16 are considered to be diagnostic of acute
infection with C. pneumoniae.
085
.1:512
Downloaded from http://jcm.asm.org/ on July 24, 2020 by guest
H-17
H-18
H-19
H-20
H-21
H-22
H-23
H-25
T2213
T2223
T2452
CF 12
P 12
CF 1
A 221
A 216
A 214
A 206
T 2251
TABLE 2. Comparison of culture, PCR-EIA, and DFA for
detection of C. pneumoniae in nasopharyngeal specimens
DIAGNOSTIC UTILITY OF PCR-EIA IN C. PNEUMONIAE DETECTION
VOL. 32, 1994
DISCUSSION
similar.
The findings of this study, however, raise a concern about
the sensitivity and specificity of serology for diagnosing active
infection with C. pneumoniae. Although many (75%) of the
asymptomatic persons had antibody to C. pneumoniae, it is
surprising that 15 (18.8%) of the asymptomatic persons had
antibody levels considered to be diagnostic of acute infection
with C. pneumoniae (5). The finding of diagnostic antibody
titers among asymptomatic patients who were culture and PCR
negative suggests that the criteria developed by Grayston et al.
for adults may not be appropriate for this population. Conversely, of the 56 symptomatic patients, 30 (53.6%) had IgG
antibody levels of -1:32, 3 had IgG antibody levels of -1:512,
and 15 (26.8%) had IgM antibody levels of -1:16. Thus, 18
(32.1%) had antibody levels considered to be diagnostic of
acute infection with C. pneumoniae on the basis of a single
serum specimen, but only 7 of these patients had a positive
culture and/or a positive PCR-EIA result. The lack of diagnostic antibody titers among 28 patients who were either PCR or
culture positive indicates a lack of sensitivity with a single
serologic specimen. If convalescent sera had been obtained,
these serologic results might have been improved. However,
treatment decisions are often based on a single specimen, and
convalescent serum is then only useful retrospectively. In
addition, the criteria for the serologic diagnosis of acute
infection as developed by Grayston et al. were based on adult
samples (5). The serologic responses may be different in
children.
In summary, these data indicate that culture positivity and/or
PCR-EIA positivity may be more reliable for the diagnosis of
acute C. pneumoniae infection than positivity by serology,
which may be nonspecific and insensitive for treatment considerations. This retrospective study of a large number of
culture-positive specimens also indicates that PCR-EIA can
detect C. pneulmoniae in clinical respiratory specimens and that
the specificity of PCR-EIA is excellent, although its sensitivity
may be improved. However, additional prospective studies are
needed to resolve the diagnostic differences between serology,
culture, and PCR-EIA.
ACKNOWLEDGMENTS
We thank L. E. Welsh, M. Gelling, and L. Ramos for technical help,
as well as Patricia Buist for editorial assistance.
REFERENCES
1. Bobo, L., F. Coutlee, R. H. Yolken, T. Quinn, and R. P. Viscidi.
1990. Diagnosis of Chlanzydia trachomatis cervical infection by
detection of amplified DNA with an enzyme immunoassay. J. Clin.
Microbiol. 28:1968-1973.
2. Fang, G. D., M. Fine, J. Orloff, et al. 1990. New and emerging
etiologies for community-acquired pneumonia with implications
for therapy: a prospective multicenter study of 395 cases. Medicine
(Baltimore) 69:307-316.
3. Gaydos, C. A., C. L. Fowler, V. J. Gill, J. J. Eiden, and T. C. Quinn.
4.
5.
6.
7.
8.
9.
10.
1993. Detection of Chilanydia pneumoniae by PCR-EIA in an
immunocompromised population. Clin. Infect. Dis. 17:718-723.
Gaydos, C. A., T. C. Quinn, and J. J. Eiden. 1992. Identification of
Chlamnydia pneuimoniae by DNA amplification of the 16S rRNA
gene. J. Clin. Microbiol. 30:796-800.
Grayston, J. T., L. A. Campbell, C. C. Kuo, et al. 1990. A new
respiratory tract pathogen: Chlamydia pneumoniae, strain
TWAR. J. Infect. Dis. 161:618-625.
Hahn, D. L., R. W. Dodge, and R. Golubjatnikou. 1991. Association of Chlamydia pneumoniae (strain TWAR) infection with
wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA
266:225-230.
Marrie, T. J., J. T. Grayston, S. P. Wang, and C. C. Kuo. 1987.
Pneumonia associated with the TWAR strain of Chlamydia. Ann.
Intern. Med. 106:507-511.
Miller, S. T., M. R. Hammerschlag, K. Chirgwin, et al. 1991. Role
of Chlamydia pnelinoniac in acute chest syndrome of sickle cell
disease. J. Pediatr. 118:30-33.
Roblin, P. M., W. Dumornay, and M. R. Hammerschlag. 1992. Use
of HEp-2 cells for improved isolation and passage of Chlanydia
pneunloniae. J. Clin. Microbiol. 30:1968-1971.
Saikku, P., M. Leinonen, L. Tenkanen, et al. 1992. Chronic
Chllamydia pneumoniae infection as a risk factor for coronary heart
disease in the Helsinki heart study. Ann. Intern. Med. 116:273278.
11. Wang, S.-P., C.-C. Kuo, and J. T. Grayston. 1979. Formalinized
Chilanydia trachomatis organisms as antigen in the micro-immunofluorescence test. J. Clin. Microbiol. 10:259-261.
Downloaded from http://jcm.asm.org/ on July 24, 2020 by guest
These results indicate that PCR-EIA of respiratory specimens can reliably detect the presence of C. pneumoniae with
relatively high sensitivity and specificity. In addition, this assay
had previously detected C. pneumoniae in respiratory specimens from a nonhuman primate model of infection (4). In this
study of 35 patients positive by either PCR or culture, 23 were
positive by both tests. There were 12 specimens that gave
discrepant results for culture and PCR-EIA. Three specimens
were culture and DFA positive but PCR-EIA negative, and
they may have contained inhibitors to the polymerase enzyme.
One of these specimens, for which additional transport media
were available, became repeatedly PCR-EIA positive when
diluted 1:10, supporting the possibility of the presence of an
inhibitor. The specimens were also tested with C. trachomatis
primers and were negative (1). Five specimens were culture
positive but PCR-EIA and DFA negative. A possible explanation for this discrepancy could be that there was too small an
aliquoted sample for adequate DFA testing. Conversely,
falsely negative PCR-EIA may be due to the presence of
inhibitory substances or to the loss of amplifiable DNA due to
nucleases in the sample. Three samples which were falsely
negative by PCR-EIA were continually PCR-EIA negative
after dilution to 1:10, and all became PCR-EIA positive when
a dilute positive control was added.
A false-positive PCR result may have been obtained for the
one specimen (087) which was culture and DFA negative but
PCR-EIA positive, especially since the specimen was PCR
negative four times upon repeat testing. The three PCR-EIAand DFA-positive specimens which were culture negative
probably were specimens with which PCR-EIA was more
sensitive than culture. The use of DFA testing of culture
transport media appeared to be a valuable way to resolve
discrepancies between culture and PCR-EIA results, but it is
difficult to define a perfect gold standard. However, when we
used the results of two tests as a gold standard, the sensitivity
of culture was better than that of PCR. Specificities were
905